Mode
Text Size
Log in / Sign up
N/A N=998 Randomized Single-blind Health Services Research

HPV Message Testing and Social Media Campaign

Vaccine · Human Papilloma Virus

Enrolled (actual)
998
Serious AEs
Results posted
Sep 2022
Primary outcome: Primary: Change in Attitudes About HPV Vaccine — .16; -.08 units on a scale — p=.003

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Social Media Message about HPV and HPV vaccine (Other); Social media message about risk of electronic cigarettes. (Other)
Age
Pediatric, Adult, Older Adult
Sex
All
Sponsor
Dartmouth-Hitchcock Medical Center
Primary completion
Sep 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Attitudes About HPV Vaccine
.16; -.08 .003 sig
SECONDARY
Behavioral Intention to Vaccinate Their Child With HPV Vaccine
-.022; -.06 >.05

Summary

This project involves a social media campaign to increase parent's knowledge and acceptance of the HPV (human papillomavirus) vaccine. The current vaccine protects against nine types of HPV, including seven that are known to cause cancer. The Centers for Disease Control and Prevention (CDC) estimates that the current HPV vaccine could prevent 90% of cancer cases caused by HPV, including cases of cervical cancer, oropharyngeal (mouth and throat) cancer, anal cancer, and others. About 150 and 104 cases of HPV-associated cancers are diagnosed each year in New Hampshire and Vermont, respectively-many of which could be prevented through vaccination. Currently, only 49.8% of New Hampshire adolescents and 44.3% of Vermont adolescents were not up-to-date for HPV vaccination as of 2016. This social media campaign is testing a set of campaign messages with parents locally and nationally to see which messages are most effective in improving their knowledge and acceptance of the vaccine. A study survey link will monitor the number of people reached and will measure parental intention to get their children vaccinated against HPV.

Eligibility Criteria

Inclusion Criteria

  • parents of children 9-14 years old

Exclusion Criteria

  • non-parents
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03747302). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search